Reckitt Benckiser Sales Beat Estimates as Retailers Stock UpBy
Shares rise as much as 6.7%, steepest gain since October 2013
Company expects cold-remedy destocking in first half of 2016
Reckitt Benckiser Group Plc, the maker of Durex condoms and Nurofen painkillers, reported fourth-quarter sales growth that beat analyst estimates as retailers stocked up on cold remedies during a slow flu season.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.